285 related articles for article (PubMed ID: 32987880)
1. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor
Yang Y; Xu X; Wu H; Yang J; Chen J; Morisseau C; Hammock BD; Bettaieb A; Zhao L
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361032
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
4. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.
Wang L; Yang J; Guo L; Uyeminami D; Dong H; Hammock BD; Pinkerton KE
Am J Respir Cell Mol Biol; 2012 May; 46(5):614-22. PubMed ID: 22180869
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
Sanders WG; Morisseau C; Hammock BD; Cheung AK; Terry CM
Am J Physiol Cell Physiol; 2012 Aug; 303(3):C278-90. PubMed ID: 22621785
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
Shrestha A; Krishnamurthy PT; Thomas P; Hammock BD; Hwang SH
J Pharm Pharmacol; 2014 Sep; 66(9):1251-8. PubMed ID: 24697323
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.
Minaz N; Razdan R; Hammock BD; Mujwar S; Goswami SK
Biomed Pharmacother; 2019 Jul; 115():108897. PubMed ID: 31102913
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
12. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
14. Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis.
Guedes AG; Morisseau C; Sole A; Soares JH; Ulu A; Dong H; Hammock BD
Vet Anaesth Analg; 2013 Jul; 40(4):440-8. PubMed ID: 23463912
[TBL] [Abstract][Full Text] [Related]
15. Anti-nociceptive efficacy of the soluble epoxide hydrolase inhibitor t-TUCB in horses with mechanically induced lameness.
Carlson A; Johnson PJ; Lei Z; Keegan KG
Res Vet Sci; 2022 Dec; 152():504-509. PubMed ID: 36174370
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
Zhang CH; Zheng L; Gui L; Lin JY; Zhu YM; Deng WS; Luo M
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):118-125. PubMed ID: 29031875
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.
Guedes AGP; Aristizabal F; Sole A; Adedeji A; Brosnan R; Knych H; Yang J; Hwang SH; Morisseau C; Hammock BD
J Vet Pharmacol Ther; 2018 Apr; 41(2):230-238. PubMed ID: 29067696
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
